Clinical Protocol

PEMF for
Neck Pain.

RCT data: PEMF reduces cervical pain by SMD=−0.89 (P<0.001) and improves disability index by 3.60 points (P=0.008). Here is the evidence base and clinical protocol for Philippine clinics treating cervical spine conditions.

← Back to Articles
Physical therapist treating patient with neck pain using advanced therapy technology

The Scale of the Cervical Pain Problem

Neck pain is the fourth leading cause of disability globally, affecting an estimated 54% of adults at some point in their lives. In the Philippines, the combination of high rates of desk-based work, extended commutes, and widespread smartphone use creates a population with chronically elevated cervical spine loading — and a correspondingly large pool of untreated or undertreated neck pain patients.

The range of cervical presentations is broad: non-specific myofascial neck pain (the most common), cervical radiculopathy (nerve root compression from disc herniation or spondylosis), cervicogenic headache, and acute torticollis. Most existing treatments — NSAIDs, collars, physiotherapy — address symptoms without modifying the underlying neurophysiology. PEMF offers a mechanism-based alternative.

Anatomy and Pathophysiology of Cervical Pain

The cervical spine (C1–C7) is the most mobile segment of the axial skeleton and the least stable — making it highly vulnerable to cumulative microtrauma and degenerative change. Key pain-generating structures include:

  • Cervical facet joints — responsible for approximately 54–67% of chronic neck pain after whiplash; richly innervated by the medial branches of the cervical dorsal rami
  • Intervertebral discs — annular tears produce discogenic pain; herniated nucleus pulposus compresses adjacent nerve roots producing radiculopathy
  • Cervical muscles and myofascial trigger points — upper trapezius, levator scapulae, sternocleidomastoid, and suboccipital muscles are the primary myofascial pain generators
  • Nerve roots (C4–C7) — compression produces dermatomal pain, paresthesia, and motor weakness in the arm and hand
  • Vertebral arteries — vascular compromise at C1–C2 from osteoarthritis or instability produces cervicogenic vertigo and headache

PEMF Mechanisms in the Cervical Spine

PEMF targets cervical pain through multiple parallel pathways:

  1. Nociceptive threshold elevation — low-frequency PEMF (10–50 Hz) raises the firing threshold of A-δ and C afferents in the cervical dorsal horn, reducing pain signal transmission without sedation or systemic side effects
  2. Anti-inflammatory cytokine modulation — PEMF suppresses IL-1β and TNF-α in periarticular and perineural tissues, reducing the chemical sensitization that perpetuates chronic cervical pain
  3. Proprioceptive restoration — electromagnetic stimulation at mechanoreceptors (Ruffini endings, Golgi tendon organs) in the cervical facet capsules restores joint position sense, addressing the proprioceptive deficits that predispose to recurrence
  4. Microcirculation enhancement — improved capillary perfusion in compressed or ischemic nerve roots accelerates remyelination and reduces radicular sensitivity
  5. Muscle hypertonicity reduction — direct effect on sarcolemmal membrane potential reduces involuntary cervical muscle co-contraction that perpetuates pain and restricts range of motion

Clinical Evidence

Cervical Radiculopathy RCT — Exercise + EMF vs. Exercise Alone (n=34)

A randomized controlled trial enrolled 34 patients with confirmed cervical radiculopathy (disc herniation or foraminal stenosis causing unilateral arm pain with positive Spurling's test) and randomized them to either exercise alone (control) or exercise plus electromagnetic field therapy (intervention), applied three times per week for four weeks. Outcomes were measured using VAS (pain), NDI (Neck Disability Index), cervical joint position error test (JPET, a proprioception measure), and CROM (Cervical Range of Motion).

Results across all outcome measures favored the electromagnetic field group:

  • VAS pain: standardized mean difference = −0.89 (95% CI: −1.34 to −0.44, P<0.001) — a large effect size indicating clinically meaningful pain reduction beyond exercise alone
  • Neck Disability Index: mean difference = −3.60 (95% CI: −6.27 to −0.94, P=0.008) — significant improvement in functional disability
  • Cervical joint position sense (JPET): significant improvement in proprioception in the EMF group, addressing the sensorimotor deficit that perpetuates recurrent cervical episodes
  • Range of motion (CROM): significant improvement in cervical flexion, extension, and lateral rotation

The proprioception finding is particularly clinically significant for Philippine clinics: cervical radiculopathy patients with impaired joint position sense are at high risk of recurrence — PEMF's restoration of proprioceptive function addresses this directly, increasing long-term treatment value.

PMC7018371 — Cervical Disc Herniation RCT (Cervical PEMF, n=63)

A double-blind, prospective, randomized, placebo-controlled trial (n=63; 33 PEMF, 30 sham) assessed PEMF applied to the cervical area for 20 minutes per session (10–100 Hz) over 15 sessions in patients with cervical disc herniation. Both groups received conventional physiotherapy as a base. Significant improvements were recorded in VAS pain and Nottingham Health Profile sleep quality at the 12-week follow-up — indicating that PEMF's pain-modulating effect extends well beyond the treatment period.

This study's 12-week follow-up data is particularly valuable for justifying PEMF to clinic investors: the durability of effect means patients benefit for months after completing a course, increasing referrals through improved outcomes.

Clinical Protocol for Neck Pain

Parameter Non-Specific Neck Pain Cervical Radiculopathy
Coil placement Posterior cervical, bilateral upper trapezius Cervical spine + ipsilateral shoulder/arm for referred pain
Frequency 10–50 Hz (pain/muscle focus) 50–100 Hz (nerve root focus)
Intensity Medium (50–70% device capacity) Medium-high (60–80%); titrated to tolerance
Session duration 20 minutes 25–30 minutes
Sessions per week 2–3 3 (as per RCT protocol)
Total course 6–10 sessions 12–15 sessions
Adjuncts Ergonomic coaching, postural exercise Neural mobilisation exercises post-PEMF, cervical traction if indicated

PEMF vs. Other Neck Pain Treatments

Treatment Evidence Level Pain Reduction Addresses Radiculopathy Proprioception Benefit
PEMF therapy RCT (P<0.001) SMD=−0.89 (large) Yes Yes (JPET improvement)
NSAIDs / analgesics RCT (moderate) Moderate; systemic Partially (anti-inflammatory only) No
Physiotherapy (exercise) RCT (moderate) Moderate alone Partially Partially (with targeted training)
Manual therapy / manipulation Systematic review (moderate) Moderate Caution: contraindicated in some radiculopathy Partially
Corticosteroid injection RCT (moderate) Good short-term Yes (epidural) No
Surgery (ACDF) RCT (strong for severe) High for severe radiculopathy Yes No

Condition-Specific Considerations

Non-Specific Myofascial Neck Pain

For the largest patient category — chronic postural neck pain without radiculopathy — PEMF is best deployed as a primary modality rather than an add-on. When used as monotherapy (rather than adjunct to physiotherapy), PEMF demonstrates cleaner differentiation from sham in the literature. Combining PEMF with ergonomic coaching and postural exercise yields the most durable outcomes.

Cervical Radiculopathy

PEMF's strongest cervical evidence is in radiculopathy, where it outperforms exercise alone on VAS (P<0.001), NDI (P=0.008), and proprioception. The mechanism is likely dual: direct anti-inflammatory effect on the compressed nerve root plus central pain modulation at the dorsal horn. Protocol should target the symptomatic level with periradicular coil placement.

Cervicogenic Headache

Cervicogenic headache originates from upper cervical facet joints (C2–C3) and suboccipital musculature. PEMF applied to the posterior cervical and suboccipital regions addresses both the articular and myofascial contributors. Clinical experience across Israeli clinics shows significant headache frequency reduction after 4–6 PEMF sessions in this indication.

Contraindications

Standard PEMF contraindications apply to cervical treatment:

  • Active pacemaker, cochlear implant, or other implanted electronic device — absolute contraindication; check for any device before coil placement near the cervical region
  • Active malignancy at or near the treatment site
  • Acute inflammatory or febrile illness
  • Active epilepsy with uncontrolled seizure frequency
  • Pregnancy (general caution, though upper cervical region is anatomically distant from uterus)
  • Vertebral artery insufficiency — PEMF is safe but patient positioning for coil access should avoid provocative neck positions

The Philippine Market Opportunity

Neck pain is one of the most clinically underserved conditions in the Philippine outpatient system. The available options for most patients are paracetamol, NSAIDs, or limited physiotherapy — with no access to evidence-based non-pharmacological modalities. PEMF fills this gap with a technology that has an RCT-verified large effect size (SMD=−0.89), requires no prescription, and can be administered in any clinic setting.

The target patient profile — working adults aged 25–55 with chronic or recurrent neck pain — is the highest-volume segment of the urban Philippine outpatient market. Average PEMF treatment courses for neck pain run 8–12 sessions (₱12,000–₱30,000 per patient cycle), with high rates of repeat treatment given the recurrent nature of the condition. This positions neck pain as one of the top-3 volume drivers for a new PainFree clinic, alongside low back pain and osteoarthritis.

Request the full investor package — including market sizing, equipment specifications, and projected per-clinic financials for the Philippines.

Request Investment Brief →